Pacific Biosciences OF California, Inc. company insiders have only been selling lately: four insiders unloaded about $3.4 million of stock over 12 months, with no open-market purchases.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
3 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Gibson James R II | Officer | Sell | 661,815 | $3.11 | $2.1M | SEC |
| Aug 18, 2026 | Van Oene Mark | Officer | Sell | 26,911 | $1.13 | $30K | SEC |
| Apr 3, 2026 | Gibson James R II | Officer | Sell | 88,185 | $1.37 | $121K | SEC |
| Mar 4, 2026 | HENRY CHRISTIAN O | Officer | Sell | 12,497 | $1.51 | $19K | SEC |
| Mar 4, 2026 | Van Oene Mark | Officer | Sell | 6,504 | $1.51 | $10K | SEC |
| Mar 4, 2026 | Farmer Michele | Officer | Sell | 2,979 | $1.51 | $4K | SEC |
| Feb 19, 2026 | Van Oene Mark | Officer | Sell | 55,107 | $1.63 | $90K | SEC |
| Feb 19, 2026 | Van Oene Mark | Officer | Sell | 129,790 | $1.58 | $205K | SEC |
| Feb 19, 2026 | HENRY CHRISTIAN O | Officer | Sell | 140,874 | $1.63 | $230K | SEC |
| Feb 19, 2026 | HENRY CHRISTIAN O | Officer | Sell | 331,793 | $1.58 | $524K | SEC |
| Feb 19, 2026 | Farmer Michele | Officer | Sell | 14,952 | $1.63 | $24K | SEC |
| Feb 19, 2026 | Farmer Michele | Officer | Sell | 35,215 | $1.58 | $56K | SEC |
| Aug 20, 2025 | Van Oene Mark | Officer | Sell | 26,836 | $1.31 | $35K | SEC |
| May 21, 2025 | Farmer Michele | Officer | Sell | 5,195 | $1.00 | $5K | SEC |
| Mar 5, 2025 | Van Oene Mark | Officer | Sell | 6,486 | $1.41 | $9K | SEC |
In the last 12 months Pacific Biosciences OF California, Inc. insiders made open-market purchases worth about $0 and sales worth about $3.4 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PACB was filed on 2026-10-08.
No congressional trades in PACB were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).